What biotech finance teams need from budgeting software
Biotech budgets follow programs, and programs follow science that changes. A slipped first-patient-in or a CRO change order moves spend by quarters, and your board wants the new cash-out date the same day. A department-by-month budget can't answer that question without a rebuild.
Here is what we would test in any tool before looking at a price.
What to look for | Why it matters in biotech | What to ask the vendor |
Budgets by program, study and site | R&D spend hides inside cost centers unless it rolls up by program | Can I see cost to complete for one study? |
CRO and vendor commitments | Contracts drive most clinical spend, and invoices arrive late | How do accruals work when site data is delayed? |
Runway under scenarios | A trial delay changes the date cash runs out | Change one milestone date and show me the new runway |
A live link to your general ledger | A budget that isn't tied to actuals turns every variance review into a translation exercise | Which ERPs connect natively today? |
Who maintains the model | Biotech finance teams are small, and protocols change | Who updates the model after a protocol amendment? |
Board and investor reporting | Investors ask about burn, variance and runway | Can I build the board view without exporting to a spreadsheet? |
Two planning numbers are worth loading into your model before any demo. Glencoyne's biotech budgeting guide recommends a 15 to 20 percent contingency on CRO and CMO contracts, and 30 percent or more for recruitment delays and unexpected adverse events in trial budgets. If a tool can't carry contingency as a visible line you can flex, you will end up hiding it in a spreadsheet next to the tool.
The ledger link deserves its own sentence. CFGI, which advises clinical-stage biotechs, names a GL-integrated budget as one of the six most common gaps it sees, because budget-to-actual comparisons only work when the budget and the books use the same structure.
Biotech budgeting software compared
Tool | Built for | Biotech-specific capability | Systems it names | Go-live time it publishes |
Abacum | Finance teams planning R&D, clinical and G&A spend | Spend by program, study and site; CRO and grant tracking; runway that recalculates | NetSuite, Sage Intacct, Snowflake, BigQuery | Most teams live in about 6 weeks |
Condor | Biopharma clinical finance | Trial-level scenario modeling, automated accruals, cost to complete | ERP, EDC, CTMS | Not published |
Caladan | Clinical-stage biotech | Trial cost and enrollment forecast with P10/P50/P90 range; expected invoice register from CRO contracts | QuickBooks, BILL.com (NetSuite listed as coming soon) | Not published |
Anaplan | Larger life sciences organizations | R&D portfolio planning, clinical and commercial planning, pharma IBP | Not published | Not published |
Planful | Teams that need close, consolidation and planning together | Program expense planning and clinical scenarios (Apollo Therapeutics) | Existing ERP, Power BI | Apollo went live in under 2 months |
Pigment | Connected planning across commercial, R&D and finance | Patient-based sales forecasting and R&D planning by trial milestone, through partner Statera | Not published | Partner-led |
Cube | Teams that plan in Excel and Google Sheets | Spreadsheet sync to a governed model; healthcare page covers facilities and payers | Sage Intacct, Workday, ADP, data warehouses (healthcare page examples) | Not published |
Tool-by-tool notes
Abacum
Abacum tracks R&D, clinical and G&A spend by program, study and site, and refreshes from your actuals instead of CSV pulls. It connects to NetSuite, Sage Intacct, Snowflake and BigQuery, in addition to supporting 700+ other integrations. Grant budgets, drawdown and CRO commitments sit in the same model as the rest of the plan, so restricted funding doesn't need its own spreadsheet for every study.
Runway is the reason most biotech teams come to us. Move a protocol date, an enrollment delay or a milestone, and burn and cash-out date recalculate. Abacum Intelligence flags the anomaly, drafts the formula and explains what changed, with the numbers visible so you can check them before the board sees the slide. INBRAIN Neuroelectronics, a medical device company, closed a Series B with investor-ready financials built in Abacum. Our native FP&A for biotech session walks through CRO cost models by phase, site, patient and milestone.
Abacum is SOC 2 Type II, ISO 27001 and GDPR compliant, and most teams go live in about six weeks, depending on the number of entities and how clean the data is.
Condor
Condor is built around clinical finance. Its FP&A product models scenarios at the trial level, pulls ERP, EDC and CTMS data into one model, and automates accruals, including anticipated visits, procedures and invoiceables when site data arrives late. An AI agent explains variance and cost to complete. Condor advertises forecast accuracy above 90 percent, which is a vendor claim worth testing against your own trials during a pilot.
The value depends on connecting your EDC and CTMS systems, so ask who does that integration and how long it takes.
Caladan
Caladan targets clinical-stage biotech and links trial budgets, vendor spend, forecast and runway in one model. Its TrialCast module forecasts clinical cost and enrollment and shows cost as a P10, P50 and P90 range from a Monte Carlo simulation, with defaults benchmarked against more than 70,000 trials in the ClinicalTrials.gov AACT dataset. VendorCast reads CRO and vendor contracts into an expected invoice register, and a person confirms each entry before anything posts.
Actuals come from QuickBooks and BILL.com, with NetSuite listed as coming soon. The runway module (RunwayMap) and the board reporting module (ExecReady) are also listed as coming soon, so confirm what is live on your demo date.
Anaplan
Anaplan sells an integrated financial planning application for life sciences that connects R&D, clinical operations and commercialization, plus integrated business planning for pharma that covers R&D portfolio planning, demand and supply. A top 15 global pharmaceutical company cut the planning cycle in its largest unit by a month on the platform.
The breadth suits organizations planning across the whole value chain. For a pre-commercial company with one or two lead assets, it may be more platform than you need yet.
Planful
Planful's clearest biotech story is Apollo Therapeutics, which manages more than 20 research programs and up to 600 activities at a time. Apollo started with multicurrency close and consolidation, went live in under two months with a Planful partner, then added operating expense planning, workforce planning and clinical and nonclinical program scenarios. Reforecasting moved from quarterly to monthly, and more than 20 department heads and program leads now run self-serve reports.
If formal close and consolidation sit on your must-have list, this is the documented biotech example to study.
Pigment
Pigment's life sciences material comes through its partner Statera. The Life Science Asset forecasts patient-based sales, plans R&D expense by clinical trial milestones and cost drivers, and connects each functional model back to the financial statements. That suits companies planning a commercial launch and R&D in one connected model.
Cube
Cube keeps finance in Excel and Google Sheets and syncs both directions to a governed model. Its published healthcare page centers on facilities, payers and programs, and lists HIPAA compliance and SOC 2 Type II. The biotech content we found is a 2024 product tour for healthcare and biotech finance teams. If your team won't give up its spreadsheets, Cube deserves a look, and you should ask for biotech references because the industry page is written for healthcare providers.
How to choose
If cost to complete on each trial is your hardest number, start with Condor or Caladan.
If your board asks about runway every month and your ledger is NetSuite or Sage Intacct, start with Abacum.
If you are planning a commercial launch alongside R&D, look at Anaplan or Pigment.
If you need multicurrency close and consolidation in the same tool as planning, look at Planful.
If spreadsheets are non-negotiable, look at Cube.
Our own view is that most clinical-stage teams should settle the link between budget and general ledger before they buy trial-level modeling. A detailed trial model built on numbers that don't tie to the books hands the board a second version of the truth, and it tends to surface during a financing round.
Five questions to ask in every demo
Move first-patient-in back one quarter. How long until runway updates, and who does the work?
Show me cost to complete for one study with CRO commitments included.
What happens to the forecast when site data is late?
Which ERP connections are live today, and which are on a roadmap?
Who maintains the model after go-live, and what do they need to know?
Frequently asked questions
What is the best budgeting software for a biotech company?
It depends on your stage and your hardest number. Teams whose main problem is trial cost to complete often start with Condor or Caladan. Teams that need program-level budgets, CRO and grant tracking and a runway the board can trust often start with Abacum. Larger organizations planning R&D and commercial together look at Anaplan or Pigment.
Do biotech companies need life sciences-specific planning software?
Not always. A general FP&A platform can work if it tracks spend by program and study, carries CRO commitments, and recalculates runway when dates move. Life sciences-specific tools add trial-level data feeds such as EDC and CTMS, which matter most when clinical operations and finance work from different systems.
Can budgeting software track grants and CRO spend?
Yes, in several tools. Abacum tracks grant budgets, drawdown and CRO spend against restricted funding in one model. Caladan's VendorCast turns CRO and vendor contracts into an expected invoice register. Condor automates accruals from trial activity.
How long does implementation take?
Most teams using Abacum go live with their first use case in about six weeks. Most other vendors don't publish a timeline, so ask for one in writing and ask what your team has to do during it.
How much does biotech budgeting software cost?
Most vendors don't publish pricing. Growing companies evaluating Pigment are typically quoted around $60K before discounts for Pigment Essentials. Ask every vendor for a quote that includes implementation partner fees and any admin time you will need to budget for.
Try it with your own numbers
Bring a real budget to a demo. We will load your programs, connect your ledger, move a milestone and show you the runway change in the meeting.
Book a personalized demo or read more on our life sciences page
